Marker Therapeutics Inc (MRKR)

[microcapbiotech]

OK, "No. This was one of the first people dosed in the safety lead in."

SO, unless I'm crazy, results in the future, using the "9 day 4 X better" should produce MUCH BETTER outcomes.

"Yes. It does seem that way."

Ok, like you and Hanscott said, makes sense, seems reasonable, it's just that the timing and share price suck, but may be better in the long run (if we can make it there).

"The patients they are treating have already failed multiple lines of treatment. I think in the PI it was 4-10 prior lines of therapy failed.
The active patients are running out of options and nothing is working.
The chance of curing them is small."

Then God I hope the FDA isn't expecting miracles, if it helps some people, then it helps some people, that beats the hell out of NOTHING. WTF?

P.S. Thanks again for your responses.